Columns

42 column results
   Page  of 5  
  • Peter Norman
    The Changing Face of Insulin Treatments: The technological changes since insulin was first used as a treatment for diabetes have been transformative and market for treatments has changed as the technology has evolved. In this column, Peter Norman takes a look at these changes in the market and speculates about potential changes in the future Read more
     October 14,2014 by Peter Norman
  • Andrew Love
    Auditing Artwork Processes and Services – Tips 1 to 4: Our Columnist Andrew Love is back with a new series of articles on auditing of artwork processes and services. Like some of his other articles, this takes the format of a series of tips to cover different aspects of an artwork services and the some of the issues you should consider if preparing for or undertaking an audit. This column covers topics including Quality Management Systems Read more
     October 27,2014 by Andrew Love
  • Andrew Love
    Managing Serialisation – How to Start Development of Your Strategy and Implementation: In the final article in his serialisation series, Andrew Love looks at what needs to be done to commence the development of your strategy and implementation of your solutions. Andrew outlines the challenges you are likely to face such as identifying and interpreting the emerging and evolving legislation or Understanding the immature and evolving solution supply base and selecting appropriate implementation partners. He outlines solutions to these problems to clear your path to serialisation implementation Read more
     September 11,2014 by Andrew Love
  • Eric Langer
    Biopharma Suppliers’ Budgets Increase: Bellwether for Better Times: Biopharmaceutical companies have weathered a rough recession, layoffs, and budget trimmings. These cutbacks have affected their vendors as well. In BioPlan Associates’ 8th Annual Report and Survey of Biopharmaceutical Manufacturing, we surveyed 352 biotherapeutic manufacturers, and 180 of their vendors, in 32 countries. The substantial budget cuts at vendors that started in 2008 have begun to turn around. We measured 10 budget areas for vendors to this industry. Sales budgets, the only area that did not take a downturn, continued to increase, this year, by an average of 5% globally. Read more
     December 15,2011 by Eric Langer
  • Eric Langer
    Higher Tech Outsourcing Repositions CMOs: While many biomanufacturers continue to view outsourcing as part of their cost reduction approach, more are considering how they can incorporate outsourcing of the technical more complex upstream and downstream operations as part of their business strategy. If biopharma companies hold to these plans, the outsourcing arena may change considerably over the next few years. Read more
     September 7,2011 by Eric Langer
  • Tony Hitchcock
    Where Next for Single Use Systems?: With the on-going maturation of single use systems, one of the growing discussions is on the topic of standardisation. With many companies and organisations being at cross purposes when it comes to these standards, it is up for debate whether standardisation will be possible. In this column, Tony Hitchcock dissects the issues surrounding this topic and asks whether this debate will ever be resolved. Read more
     June 12,2014 by Tony Hitchcock
  • Tony Hitchcock
    Flexible Facilities- Single Use Systems: It is quite clear that flexible Facilities is currently a “hot” topic with a number of presentations and meetings being solely focused on this area. It has been clear for a number of years that single use systems have opened up a whole new area of possibilities with regards to facility requirements and operational models and that we are now seeing this concept turning into reality. Read more
     December 9,2013 by Tony Hitchcock
42 column results
   Page  of 5  



Advertise With Us

Join the Pharmas IQ Community